Piet Ost
Expertise in
8
conditions

Piet Ost

26656Ghent University, 
Gent, VLG, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
8
conditions
26656Ghent University, 
Gent, VLG, BE 

Overview

Piet Ost practices practicing medicine in Gent, Belgium.

Ost is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Orchiectomy.

They are actively involved in clinical research, co-authoring 330 peer reviewed articles and participating in 4 clinical trials.

Locations

26656Ghent University, Gent, VLG 2665, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Stereotactic Body Radiotherapy in Addition to Standard of Care Treatment in Patients With Rare Oligometastatic Cancers (OligoRARE): a Randomized, Phase 3, Open-label Trial
Stereotactic Body Radiotherapy in Addition to Standard of Care Treatment in Patients With Rare Oligometastatic Cancers (OligoRARE): a Randomized, Phase 3, Open-label Trial
Enrollment Status: Recruiting
Publish Date: August 26, 2024
Intervention Type: Radiation
Study Phase: Not Applicable
PEACE V: a Randomized Phase II Trial for the Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)
PEACE V: a Randomized Phase II Trial for the Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)
Enrollment Status: Active_not_recruiting
Publish Date: December 09, 2024
Intervention Type: Drug, Radiation, Procedure
Study Drug: Androgen deprivation therapy
Study Phase: Phase 2
Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases: a Randomized Phase II/III Trial
Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases: a Randomized Phase II/III Trial
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT): A Prospective Biomarker Study
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT): A Prospective Biomarker Study
Enrollment Status: Completed
Publish Date: December 01, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

330 Total Publications

Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005.
Re: Riccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005.
Journal: European urology oncology
Published: February 04, 2026

Frequently Asked Questions about Piet Ost

Is Piet Ost a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Piet Ost is classified as an Elite expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Piet Ost participate in research or clinical trials?

Yes. Piet Ost has published 330 articles and abstracts on conditions like Prostate Cancer. You can view a list of Piet Ost's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ost's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile